Notes / Company

CORONA Remedies Ltd.

CORONA BSE 544644 ISIN INE02ZQ01018 Pharmaceuticals

Fundamentals

Market cap: ₹11,579 cr
P/E: 62.55×
ROE: 24.79%
Debt / equity: 0.19
Div yield: 0.51%
52-week range: 1336.60 — 2100.70

Research on Tijori Finance

Company snapshot

CORONA Remedies Ltd.

Pharmaceuticals

₹12,162 cr

P/E 65.70×

Latest quarter · Mar 2026

Sales₹353 cr

Net profit₹45 cr

Op. margin+17.6%

EPS₹7.41

Strength & growth

Debt / equity0.19×

Current ratio0.97×

The timeline — 1 note on CORONA Remedies Ltd.

June 2026

30 Jun 26 · 4:36 PM IST Lead

Lead · Mid cap

Corona Remedies fires up EU-GMP hormone plant, adds 20% capacity

The new Ahmedabad facility, spanning 1 lakh sq ft, targets regulated export markets with 194M tablets/capsules annual capacity, turning a regulatory milestone into revenue generation.

Verify on exchange BSE filings for CORONA NSE filings for CORONA Tijori Finance company page